STOCK TITAN

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has announced the release date for its third quarter 2024 financial results. The company will disclose its financial performance before U.S. markets open on Tuesday, November 5, 2024. Following the release, SOPHiA GENETICS will host a conference call at 8:00 a.m. EDT / 2:00 p.m. CET to discuss the financial results and provide a business outlook. Investors and interested parties can access the webcast live on the SOPHiA GENETICS Investor Relations Website. For those unable to attend the live call, a replay will be made available on the company's website after the event's conclusion.

SOPHiA GENETICS (Nasdaq: SOPH), una società di software nativa del cloud specializzata in medicina basata sui dati, ha annunciato la data di rilascio dei suoi risultati finanziari del terzo trimestre 2024. L'azienda comunicherà le sue performance finanziarie prima dell'apertura dei mercati statunitensi martedì 5 novembre 2024. Dopo il rilascio, SOPHiA GENETICS terrà una conference call alle 8:00 EDT / 14:00 CET per discutere i risultati finanziari e fornire un'analisi dell'andamento commerciale. Gli investitori e le parti interessate possono accedere alla diretta della webcast sul sito delle relazioni con gli investitori di SOPHiA GENETICS. Per coloro che non possono partecipare alla chiamata dal vivo, sarà disponibile una registrazione sul sito web dell'azienda dopo la conclusione dell'evento.

SOPHiA GENETICS (Nasdaq: SOPH), una empresa de software nativa de la nube especializada en medicina basada en datos, ha anunciado la fecha de lanzamiento de sus resultados financieros del tercer trimestre de 2024. La compañía divulgará su desempeño financiero antes de la apertura de los mercados estadounidenses el martes, 5 de noviembre de 2024. Después del lanzamiento, SOPHiA GENETICS realizará una conferencia telefónica a las 8:00 a.m. EDT / 2:00 p.m. CET para discutir los resultados financieros y proporcionar una perspectiva empresarial. Los inversores y las partes interesadas pueden acceder a la transmisión en vivo en el sitio web de Relaciones con Inversores de SOPHiA GENETICS. Para aquellos que no puedan asistir a la llamada en vivo, se pondrá a disposición una repetición en el sitio web de la empresa después de la conclusión del evento.

SOPHiA GENETICS (Nasdaq: SOPH), 데이터 기반 의학을 전문으로 하는 클라우드 네이티브 소프트웨어 회사,가 2024년 3분기 재무 성과 발표일을 발표했습니다. 이 회사는 2024년 11월 5일 화요일, 미국 시장 개장 전에 재무 성과를 공개할 예정입니다. 발표 후 SOPHiA GENETICS는 동부 표준시 기준 오전 8시 / 중앙 유럽 표준시 기준 오후 2시에 재무 결과를 논의하고 기업 전망을 제공하기 위한 컨퍼런스 콜를 진행합니다. 투자자 및 관심 있는 당사자는 SOPHiA GENETICS 투자자 관계 웹사이트에서 생중계에 접근할 수 있습니다. 생중계 참여가 불가능한 경우, 행사 종료 후 회사 웹사이트에서 녹화본이 제공됩니다.

SOPHiA GENETICS (Nasdaq: SOPH), une entreprise de logiciels native du cloud spécialisée dans la médecine basée sur les données, a annoncé la date de publication de ses résultats financiers du troisième trimestre 2024. La société divulguera ses performances financières avant l'ouverture des marchés américains le mardi 5 novembre 2024. Suite à la publication, SOPHiA GENETICS tiendra une conférence téléphonique à 8h00 EDT / 14h00 CET pour discuter des résultats financiers et fournir un aperçu des affaires. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct sur le site Web des relations investisseurs de SOPHiA GENETICS. Pour ceux qui ne peuvent pas assister à l'appel en direct, un replay sera disponible sur le site Internet de l'entreprise après la conclusion de l'événement.

SOPHiA GENETICS (Nasdaq: SOPH), ein cloud-basiertes Softwareunternehmen, das sich auf datengestützte Medizin spezialisiert hat, hat das Veröffentlichungsdatum für seine Finanzergebnisse des dritten Quartals 2024 bekannt gegeben. Das Unternehmen wird seine finanzielle Performance vor der Eröffnung der US-Märkte am Dienstag, den 5. November 2024, bekannt geben. Nach der Veröffentlichung wird SOPHiA GENETICS eine Telefonkonferenz um 8:00 Uhr EDT / 14:00 Uhr CET abhalten, um die Finanzergebnisse zu erörtern und einen Ausblick auf das Geschäft zu geben. Investoren und interessierte Parteien können die Live-Übertragung auf der Website der Investorenbeziehungen von SOPHiA GENETICS verfolgen. Für diejenigen, die nicht an der Live-Konferenz teilnehmen können, wird eine Aufzeichnung nach Abschluss der Veranstaltung auf der Unternehmenswebsite zur Verfügung gestellt.

Positive
  • None.
Negative
  • None.

BOSTON and ROLLE, Switzerland, Oct. 22, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the third quarter of fiscal year 2024 before U.S. markets open on Tuesday, November 5, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-third-quarter-2024-on-november-5-2024-302281898.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) release its Q3 2024 financial results?

SOPHiA GENETICS (SOPH) will release its third quarter 2024 financial results before U.S. markets open on Tuesday, November 5, 2024.

What time is the SOPHiA GENETICS (SOPH) Q3 2024 earnings conference call?

The SOPHiA GENETICS (SOPH) Q3 2024 earnings conference call is scheduled for 8:00 a.m. EDT / 2:00 p.m. CET on November 5, 2024.

How can I access SOPHiA GENETICS (SOPH) Q3 2024 earnings call?

The SOPHiA GENETICS (SOPH) Q3 2024 earnings call will be webcast live on the SOPHiA GENETICS Investor Relations Website. A replay will also be available on the website after the call.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

209.95M
62.57M
5.82%
50.04%
0.04%
Health Information Services
Healthcare
Link
United States of America
Rolle